Inventor
ENGLEMAN EDGAR G
US31 patents
⚠️ This page may combine multiple inventors who share the name “ENGLEMAN EDGAR G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV LELAND STANFORD JUNIOR
22 patentsUS4634666AJan 6, 1987
Human-murine hybridoma fusion partner
UNIV LELAND STANFORD JUNIOR338 citations97
US7098184B2Aug 29, 2006
Method of treating rheumatoid arthritis and multiple sclerosis diseases of the human immune system
UNIV LELAND STANFORD JUNIOR27 citations95
US6528623B2Mar 4, 2003
Antibodies that specifically bind ACT-4-L-h-1 ligand
UNIV LELAND STANFORD JUNIOR33 citations95
US6277962B1Aug 21, 2001
Receptor on the surface of activated t-cells: act-4
UNIV LELAND STANFORD JUNIOR40 citations95
US6242566B1Jun 5, 2001
Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
UNIV LELAND STANFORD JUNIOR27 citations95
US5821332AOct 13, 1998
Receptor on the surface of activated CD4+ T-cells: ACT-4
UNIV LELAND STANFORD JUNIOR51 citations95
US7364733B2Apr 29, 2008
Antibody to receptor on the surface of activated T-cells: ACT-4
UNIV LELAND STANFORD JUNIOR15 citations92
US6528055B2Mar 4, 2003
Methods of administering antibodies that specifically bind ACT-4-L-h-1 ligand
UNIV LELAND STANFORD JUNIOR22 citations92
US6156878ADec 5, 2000
Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
UNIV LELAND STANFORD JUNIOR21 citations92
US5415874AMay 16, 1995
Natural killer cell lines and clones with antigen specificity
UNIV LELAND STANFORD JUNIOR74 citations91
US6423539B2Jul 23, 2002
Adjuvant treatment by in vivo activation of dendritic cells
UNIV LELAND STANFORD JUNIOR36 citations87
US6821778B1Nov 23, 2004
Methods for using dendritic cells to activate gamma/delta-T cell receptor-positive T cells
UNIV LELAND STANFORD JUNIOR45 citations86
US10583125B2Mar 10, 2020
Method for treating neurodegenerative diseases
UNIV LELAND STANFORD JUNIOR8 citations82
US10272070B2Apr 30, 2019
Method for treating neurodegenerative diseases
UNIV LELAND STANFORD JUNIOR11 citations82
US5567696AOct 22, 1996
Treatment of systemic lupus erythematosus with dehydroepiandrosterone
UNIV LELAND STANFORD JUNIOR17 citations77
US7125670B2Oct 24, 2006
Ligand (ACT-4-L) to a receptor on the surface of activated CD4+T-cells
UNIV LELAND STANFORD JUNIOR6 citations73
US10653669B2May 19, 2020
Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation
UNIV LELAND STANFORD JUNIOR5 citations71
US4471056ASep 11, 1984
Method for HLA-DR typing of total human lymphocyte sample
UNIV LELAND STANFORD JUNIOR16 citations69
US5817650AOct 6, 1998
Treatment of systemic lupus erythematosus with dehydroepiandrosterone
UNIV LELAND STANFORD JUNIOR10 citations66
US10966962B2Apr 6, 2021
Method for treating neurodegenerative diseases
UNIV LELAND STANFORD JUNIOR0 citations60
US4657852AApr 14, 1987
Method for B cell typing of total human lymphocyte sample
UNIV LELAND STANFORD JUNIOR5 citations58
US4950598AAug 21, 1990
Process for making T cell hybridomas
UNIV LELAND STANFORD JUNIOR3 citations57
LUMEN THERAPEUTICS LLC
3 patentsUS7557087B2Jul 7, 2009
Compositions and methods for treating diseases
LUMEN THERAPEUTICS LLC36 citations94
US9220744B2Dec 29, 2015
Compositions and methods for treating diseases
LUMEN THERAPEUTICS LLC2 citations60
US7820626B2Oct 26, 2010
Compositions and methods for treating diseases
LUMEN THERAPEUTICS LLC2 citations60